GlassScriptPhysician profile
Chaiyapat Charoonbara
NPI 1861797565
$3,247.51
in general payments reported to CMS, 2019-2025
15 companies · $67.64 in 2025
The $67.64 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,085 · 2020: $1,000 · 2021: $231 · 2022: $454 · 2023: $130 · 2024: $280 · 2025: $67.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,698.31 | 2019-2020 | |
| Abiomed | $471.37 | 2021-2023 | Impella |
| Boston Scientific Corporation | $238.44 | 2019-2022 | |
| Chiesi USA, INC. | $148.56 | 2019-2021 | |
| Eagle Pharmaceuticals, INC. | $124.79 | 2024 | |
| Heron Therapeutics, INC. | $120.19 | 2022 | |
| La Jolla Pharmaceutical Company | $113.29 | 2019 | |
| Becton, Dickinson and Company | $83.05 | 2024 | Hemosphere |
| Edwards Lifesciences Corporation | $72.62 | 2024 | Hemosphere |
| Pacira Pharmaceuticals Incorporated | $66.34 | 2020-2022 | |
| Philips North America LLC | $24.40 | 2025 | Igt Devices Undivided |
| Fisher & Paykel Healthcare INC | $23.05 | 2022 | |
| Atricure, INC. | $22.93 | 2025 | Synergy Ablation System |
| Conmed Corporation | $20.31 | 2025 | Airseal |
| Csl Behring | $19.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chaiyapat Charoonbara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.